secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001185185-24-000923
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma sells 588,235 shares to director-owned entity for $200,000 at $0.34 each
--------------------------------------------------------------------------------

- Shares issued to Moran Global Strategies, owned by director James Moran, at $0.34/share.
- Total proceeds of $200,000; closing subject to NYSE American approval.
- Outstanding shares post-closing will be ~75,953,296; no warrants or options outstanding.
- Investor receives piggyback registration rights with expense cap of $2,500.
- Shares issued under Section 4(a)(2) exemption from registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000923/0001185185-24-000923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518524000923/igc20240926_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-24-000923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer